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Anti-CD34 is a monoclonal antibody that reacts with bone marrow 
progenitor cells and leukemic blasts, and is expressed on 30% to 
50% of all acute leukemias. Detection of CD34 has previously been 
restricted to flow cytometric studies. To expand the utility of CD34, 
we immunostained 46 paraffin-embedded bone marrow specimens 
with acute leukemia: results were compared with flow cytometric 
studies. CD34 reactivity was also evaluated in nine chronic leukemia 
cases, 27 malignant lymphoma cases (Hodgkin’s disease and non- 
Hodgkin’s lymphoma), six normal bone marrow specimens, and 
three benign, hyperplastic lymph node specimens. All cases that 
were CD34 positive by flow cytometry (11 of 19 B-cell precursor 
acute lymphoblastic leukemia cases, one of six T-cell acute lym- 
phoblastic leukemia cases, and seven of 21 acute myeloblastic leu- 
kemia cases) were also CD34 positive in paraffin sections. Both cell 
membrane and cytoplasmic staining was seen. The positivity per- 
centage and fluorescence intensity by flow cytometry correlated 
with the estimated number of stained cells and the intensity of im- 
munoperoxidase staining in 18 of 19 CD34-positive cases. The re- 
maining bone marrow and lymph node cases studied were CD34 
negative; prominent endothelial cell staining, however, was noted. 
This is the first report of anti-CD34 staining of acute leukemia in 
paraffin-embedded sections. In contrast to other monoclonal anti- 
bodies reactive in bone marrow paraffin sections with leukemia, 
anti-CD34 immunoperoxidase staining is limited to leukemic blasts 
and may provide useful diagnostic information when flow cytometric 
studies are not available. HUM PATHOL 23:26-32. Copyright G 1992 
by W.B. Saunders Company 
The CD34 antigen is a monomeri~~, 1 15kd protein 
that is expressed on normal hematopoietic progeni- 
tors’-” and in 30% to 50% of both acute lymphoblastic. 
and acute myeloblastic leukemia cases”-“: ma~trre lym- 
phoid and myeloid proliferations have not been shown 
to express this protein.‘” Although the gene for CD34 
has been localized to the long al-n) of’chromosome 1 in 
the region of 1 q I P/lqter and its cDNA partially se- 
quenced,“‘” the function of this protein has remained 
an enigma. 
The detection of surface and cytoplaslnic antigens 
relevant to diagnostic hematopatholog can be acco~n- 
plished by flow cytometric imJllunopherrotypirlg of single 
cell suspensions or by paraf%n section immunoperoxi- 
dase studies. Most monoclonal antibodies (MoAbs) rel- 
evant to diagnostic heJnatopatllolt)b~ are used in c.on- 
junction with flow cytometry and detect surface antigens 
that are destroyed by routme tissue fixation and pro- 
cessing,“‘-“’ Monoclonal antibodies that have been used 
in paraffin sections of bone marrow are not restricted 
to acute leukemia and usually are not lineage spc- 
cific. “‘-” Because of these limitations, paraffin section 
studies of acute leukemia have not been widely imple- 
mented. 
To expand the diagnostic repertoire of immuno- 
peroxidase studies in acute leukemia, we have compared 
anti-CD34 staining of paraffin sections of bone marrow 
with flow cytometric imrnunophenotyI,irlg of bone mar- 
row cell suspensions in 46 cases of acute leukemia and 
in 36 cases of other hematopoietic and lymphoid malig- 
nancies. The results of paraffin section staining with anti- 
CD34 paralleled those found by flow cytometric surface 
imrn~ulophenotypillg. This finding provides the pathol- 
ogist with an additional MoAb to use in evaluating pal-- 
afEn sections of acute leukemia. 
MATERIALS AND METHODS 
‘l‘hc c;w3 01’ ;I( utc Icukrmia svlec.lctl f’or this study wet-e 
chcwn i~rt~os~~c~~li\~t~l~ on the basis of havin! available both 
Ilow c ~toti~etri~ iti~ti~tttio~~h~tlotrping (includtng CD.34 slain- 
itig) ;tttd I);tt‘;tftiti-ettil,etltletl bone marrow Irephinr ;ttld/ot 
~.lot sc.t.liolrs. Forty-sis ;tt’ute leuketnias that met this c.rileria 
wet-c’srlcc3rd; all s;tbryl>c3 of’,~c.ulr lymphoicl and myeloid leu- 
kcnlia were rrpresen~~~l. ‘I‘o (.onfir~tt 111e known distributiotl 
of’ (1113 I, cvc also) ev;tlrtatc‘tl jaralfiti sections ctf‘ nine cases 01’ 
thronic Iruketnia atltl 27 cxxs ol’ tnalignant lymphorna. Six 
IIO~IJX~~ botw marrow spec~imens XXI three benign, hyperplastit. 
lymph node5 were rv;tltt;ttctl by paraffin section in~mutitq~rr- 
oxidasr slrtclies; ttirev 01’ the normal bone marrow cases wet-c 
also itnttrutio~~~~eti’,l\;petl I)y flow cylonietric analysis. Fifrren 
;tdtliticm;tl bottr m;trrow ttq)hitie biopsies wcrc also cx:mlined 
ior <:I)34 5t;tiltitlg: thvsr biopsies represented a variely of’ 
ttotttrialignant botiv ttiat~t~ou’ (‘ases. ‘[‘able I lists the tlistrit)utiort 
01 caszs sttrtlivtl by di;qgosis. ‘l‘he 46 lmr~e marrow caes with 
XIIIC leukemia included 24 witIt decalcified, B-5 fixed trephint 
biopsy 5pecinlens. IL’ with both B-5 fixed trephinc biopsy 
xptv~itttvtis ancl formalin-tixecl clot sections. and 10 with clot 
srctiorts only. Of the 27 lymph node cases, 16 werr studietl 
iti KGfixt~tl tissue antI I I ifi li~tmalin-fixed tissue. 
Flow qcotitetric itrittttttrophenotyping methods used itt 
tltih study IKIVC bern reporrcd previously.” A hro~l pane1 01’ 
lymphoitl- antl tnyeloid-asaoc.i~tt~~l MoAhs was used. B-ccll- 
associated MoAbs inclutlcd CDl!) (K-l), CD20 (Bl), and CD22 
(I.cu-I 4). ‘I‘-~cll-~tasoc.i~tt~cl MoAbs included CD I (‘IX), CD9 
(Tl I ). (:1X3 (‘1‘3). CD4 (T4). CD5 (I,eu-I), CD7 (Lcu-9). and 
(:1)X (‘1‘8). Myeloitl-~tsso~i~tle~ MoAbs included CD1 I II (1.c~ 
I :i), (11) I3 (My7). CD1 4 (My-l), and CD33 (My?)). Other MoAbs 
us~tl inc-lutlctl CD1 0 (]!I), (ID34 (HP(:A- I), and Hl.A-l)K. I” 
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TABLE 1. Immunoperoxidase Staining With Anti-CD34 
in Paraffin Sections 
-____ __.- 
(:;1scs Will1 (‘I)‘bI . 
Slaining/I‘otal 
I)~agnosis No. 01 C:ases 
:blti-C:lIS-J I I11’(:,\-I ; Ke~toll-l)ic.kirlsorl, Mountain Virw. (:A) 
wa 11set1 at ;I dilution 01‘ I : IO. The c,riterion for (X)34 positivit! 
was Iht. espl-c5sicm 01 thar antigen by at least 20%~ of chr bl;G 
c-cl1 po~~ul;~lion, if the morphologic evaluation of ;I c-ytocen- 
tr-ifiyc prcl);lration showed a high percrn~age of’ leukcnlia 
bl.isrr. In adtlition to detcrnrining~the positivity p-c.entagc 01 
crlhllar scaiI)ing with each bloAb, the mean charmcl of Iluo- 
wsct’nw in(c.nsitv was also determined. This mean channrl 
nlnnher wa:i us~tl as ;I direct indicWor of thr inrcnsitv of fh- 
01~twcnt sldining.” 
Inlrnul~opei.oxidase sraining with anti-CD34 was pet-- 
Iorriictl using well-established niettiods.“’ The smic .nitibotly 
sours (130 toll-l)ic.kinson) and dilution (1 : IO) for ;n~~i-CU3-l 
W<‘I-C used as in tlow cytometric immunophrnoty~,ill~, The in- 
tqrrtatiol~ of anti-CD34 i~nnl~inoperoxidase st&ling invoked 
both an attrnipl (0 cluantifi\; the percentage of‘ c-ells staining 
as well as a11 ~siirnale of the Intensity ofstainilig. PositiviCy was 
roughly approxiniated as follows: 0 to 25%. 25% IO 50%. .50% 
It b 75%. and 75% to IOO% I”)sitivc-staiiii[Ig crlls. l‘he intensil): 
01 slaining W;IS ;dso approximard based on the illtcnsity 01 
i1111)11111o1)(‘1-oxi~iase taining: p, ncgativ~; f, wrak sraining; i-t. 
rrtcttkxrrc~ slairiing: atlti +t+. itltrnsc sr;tinillg. 
RESULTS 
Flow Cytometric Immunophenotyping 
The tlistrilnition of’anti-<:D?A 5taiiiilrg in the* ac‘ult 
leukemia cases by flow cytometric i~nntunt:~t)ll~~ttotyt,itt~ 
was similar to that reported in previous stuclic’s.5m!’ ‘Twelvt 
of’ 25 (48%) acute lyntphocytic leukemia cxsvs and seven 
of’ ‘Ll (33%) acute myetoid leukemia cast’s in thi\ srudv 
expressed the (333 antigen. Only one of’sia ‘I‘-cell acwtr 
lyrnphoqtic leuketnias showed anti-(:DS4 srainittg. .I‘lte 
percentage of c.ells expressing CDS3, 2s dt~termirietl by 
flow cytometry, ranged from I9.296 I0 !tLO% ili ttlosc 
acute leukemia cases interpreted as beirtg t)ositive for 
CD34 (mediate, 58.4?6). The Ittem c~hmnel of‘ fluows- 
ceuce intensity of‘ atiti-CDS. which was I~tsed 011 ;t 1 
to 256, three-decade logarithntic scale. t-mged f‘roul ?ti 
to 115 channels (median, 73.X) iu the (:1)3-l-lmsitivt 
c.ases. For purposes of’ comparisou with the irtmuno- 
pm)xidase stainittg, cm3 below the ttiedi;in \I ert ;i1.- 
biLt.ar-ity interpreteci as being of dint itttcmsit!. while 
those above ttte niedian were arl)ittat4\ tlcsignatc~tl as 
beirtg of bight iuCertsity’5~” (‘fable L’!. 
lmmunoperoxidase Staining 
Results ohtaiued bv initnttrio~~r~~c~si~lase \t;titting 
with anti-CD34 paralleled those olminetl by 110~ (‘v- 
totiietric i~iititunophet~otyping (Table ‘1). I‘he \t;tiitit;g 
was distributrd both on the cell sut-fitc c’ ttt(mtbr;ttt(k :ttttl 
itt the cytoplasm; ttte rmjoritv oi‘ staining appe;trt~(l to 
be nietiibrme hound (Kg t).‘Wheti [he I)ercettt;tgr of 
ittt~ttrtnof~et-oxidase anti-CD5f scaitting was t’stirttatrd 
(Table L’), resttlts closely appt~oxittial~tl Ilit. perct’tttagc 
ofleuketni~ cells stained by flow cytotttt~tt‘\. Itt aclditiott. 
the estimate of ittitiiunopet~oxiclasr stainit’tg intensity of‘ 
attti-(;I):34 also cot-related with the ttitmt ~~ii;t~tti~~l of‘fltt- 
orcscmce intensity as deterttiin4 hc flotv ~)iio~ttett-\. 
No signifbnt ditierences in itttnttrtlot)et.osicl;tae st;tittit;g 
were noted in those cases with both B-3 al~d fomt;tliu- 
fix?d tiSSlJe. ~kdcifk~t~i~~tl Of‘thc tt?~JhillK’ hiOpSit’S h;td 
tto apparent deleleriorts effccc 011 the itilerisiry of‘(:1)34 
sraitiitig. 
Onlv otte of the 16 acu1e Ieukcutia <‘;tses showc~tl 
any significant discrepancy of mti-( :I)33 staittitig I)e- 
tween intti~uttopet~oxitiase and floM’ c~vtoiitc~ric stitdit5. 
This cast wts at1 acute ntyelogettouc Ieukcmtia (c;tsc tto. 
33) hmittg a tuean channel nutitl~et- of fl~torrsc~rttce itr- 
tcnsity of’ti6.,4, in which flow c!‘totttett‘\ sltowetl ?7.-1% 
of blast cells staining with anti-(:1)?1. In ~ottti~~l, ittt- 
tiittiiope“‘)xidasr studies showed t Iat ;it)t>t.o’iltt~ttt’l~ 
50% to 75Y0 of‘ the leukemic cells have mt irtletise (+++‘) 
atainittg t-eaction with anti-CD34 (I+?% L’) 
To assess the specificity of anti-(II):< 1 st;tiltiltg fin 
leukrtuic Masts. nine chronic IeukrtnLt (‘;Isc’~ mcl 27 ~I;I- 
lignant lytnphonia ~‘ascs were staiut.d \vit 11 aliti-(:I)Y4 in 
paraffin sections. None of’ the nitte chrottic Icttktxntia 
cases. iticludittg chronic myelogetic~its leuhcmiia. CJirottic 
lymphocytic leukemia, hairy cell Iruktmia. and tttttltiplt 
tnvelonla. showed anti-CD34 inmuttopet osidasr staitt- 
ink. Of the “7 tnalignatit lytnphotrt;r C‘;ISC’C cvalii;~ted i~t 
this study. nine were Hodgkin’s tliseaae (inclutlittg Iytn- 
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grade types; six of‘ these noll-Hodgkin’s lymphoma cases 
were of T-cell origin. Flow cytometric imrrlrlnophe~~o- 
typing was not performed in these cases. No alnli-C:1)34 
immunoperoxidase staining was found in any of the 
lymphoma cases, including four cases of lymphohlastic~ 
lymphoma (Fig 3) and three cases of Burkitt’s lymphoma 
(Fig 3). Anti-CD34 did show prominent vascular en- 
dothelial cell staining, which has been described in pre- 
vious studies (Fig 4).” In addition, there was anti-CD34 
staining of perivascular and pericapsular spindle-shaped 
c-ells (Fig 5). These CDWpositive, dendritic-like cells 
had elongated, pale-staining nuclei, 1,111 no nucleoli. 
Dendritic cells found in other locations, such 21s in IIOI'- 
Inal skin,"",'~i have previously been described by Nickolofl 
as being CD34 posiIive.‘7 
Anti-CDS4 iIll~nurlol~eroxidase staining was also 
performed on six normal bone marrow specimens, I.5 
nonmalignant bone marrow specimens, and three be- 
nign, hyperplastic lymph node specimens. Concurrent 
flow cytometric studies were done on three of the six 
normal bone marrow specimens. These three specimens 
were from children less than 2 years of age who were 
being evaluated for possible acute leukemia; morpho- 
logically, all three specimens had increased numbers of 
bone marrow hematogones, which probably represent 
human progenitor B ~~ells.‘H~2” Flow cytometric immu- 
nophenotyping in these three cases showed increased 
numbers of B-cell precursors, which were positive for 
CD10 (CAI,I,A), CD1 9, TdT, and HI,A-DR. No anti- 
CD34 staining was identified by either flow cytometry 
or paraffin section irnlnunoperoxidase in these three 
normal bone marrow specimens. The rernaining three 
normal bone marrow specimens, the 15 nonmalignant 
bone marrow specimens, and the three benign lymph 
node specimens were a11 from adult patients. No anti- 
CD34 staining of um>onuclear cells was identified in 
these benign marrow specimens or lymph nodes; only 
endothelial cells showed any imrrlunoperoxidase CDS4 
staining. Although CD&l-positive progenitor cells un- 
doubtedly were present in the bone marrow specimens. 
the extremely s~nall percentage of such cells proh- 
ably precluded their detection by iInniunoprrosidase 
methods. 
DISCUSSION 
c-llannrl of Iluorcsc~encc intensity. corrqxmding to the intensity of 
staining (1). dim staining; n. bright staining) (set twl fiw definitions). 
iI> intrnsity, al,I,~oximalion of the imll~unopc~oxidase staining intensity 
(-, neg;ttive; t. weak: +t, moderate; +++, intense). AH.(B), 1%prc- 
CL,~SO,- AI.l.; AIL(T), ‘I’-AI.1,. 
phocyte predominant, nodular sclerosing, and mixed 
cellularity types). Eighteen non-Hodgkin’s lymphoma 
cases were also evaluated, including representative sub- 
types from low-grade, intermediate-grade, and high- 
The CD34 protein is an intriguing molecule rhal 
undoubtedly plays a major role in progenitor cell de- 
velopment. In addition to its presence on hernatopoietic 
stern cells’-’ and endotlielial cells,“” a recent report has 
described a distinctive CDWpositive population of‘ cells 
located in the perifollicular “bulge” area on the hair 
follicle”7 that appears to represent the hair follicle stem 
cells.“” The biochemical properties of‘ the CD:34 protein 
along with its expression on both endothelial and hone 
marrow progenitor cells suggest that it may have an 
adhesion-like funrt ion that could enhance the interac- 
tion between progenitor cells and their surrounding 
stromal c-ells. “.” This interaction would <give the pro- 
genitor cells a direct source of needed cytokincs and 
interleukins necessary for cellular development and dif- 
ferentiation. 
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FIGURE 1. Anti-CD34 immunoperoxi- 
dase staining of acute lymphoblastic 
leukemia (case no. 4). Both cell mem- 
brane and cytoplasmic staining is seen. 
(Magnification X400.) 
111 dlition to its potential importance in Ileniato- 
fxCctic cellular developinent, CD34 expression has heen 
rwd in diagnostic irnmunophenotyping 21s a leukemia- 
restric-ted lnarker”!‘; various MoAbs (My 10, PH(:A-1 , 
Hi-3(X, I(:HS, 12.8, 8G12) have been develof~ed that 
recx@ze this xltigen. Although not lineage restricted 
to either IS- or l‘-lymphocyte fxecursors or mveloblasts. 
;mti-CD33 staining is restricted to norn~al fwogenicor 
c~fls or Iwkemic blasts anlong bone nw-row cdls. <:o- 
operative grouf) studies of’ CD34-positive xutc fym- 
fd~oc-ytic lertkctni;t in the fwdiatric age group h:rvc sug- 
gested tli:it (:1)34 expression ~nay dehne il siihgrouf~ of. 
leukernias \vith ;l good clinical fxognosis.” (conversely, 
CD34 cxfxession in adult patients with acute nlyelog- 
enous leukenlia has heen associatrcl with sllorter remis- 
sions xicl a fx)orrr clinical outcome. Kr;+wtlless of its 
potential clinicd relevancy, the esf,ression on leukenlic 
cells has helped define some of‘ the secfuenfial strfx of 
normal henlatopoietic and lymphoicl tlcvc~lof~mt~n~.“‘~” 
Par~iffin-rlnbedded sections tin\c incrcxingly been 
used 2s xi xldilional source of n~att~rial t.01. ininiuno- 
f~ficnotyf%ng in diagnostic. henlatc~f~~lfflc~lo~~. 7‘tic we of 
FIGURE 2. Anti-CD34 immunoperoxi- 
dase staining of acute myeloblastic 
leukemia, FAB-M2 (case no. 33). An in- 
tense staining reaction is seen in ap- 
proximately 50% to 75% of the leukemic 
cells. Both the percentage of positivity 
and the estimation of staining intensity 
are much greater than corresponding 
results obtained by flow cytometry. 
(Magnification ~400.) 
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FIGURE 3. Anti-CD34 immunoperoxi- 
dase staining in a lymph node section 
of T-cell lymphoblastic lymphoma. No 
CD34 staining is identified. (Magnifica- 
tion x200.) 
pzraRiin material with imtnunoperoxidase staining has 
permitted retrospective analysis and has provided di- 
agnostic. material in those cases without fresh, single- 
cell suspensions. Only a limited number of studies have 
evaluated the utility of MoAhs in paraffin sections of 
bone marrow. “‘-“(’ In general, the antibodies used for 
these studies are not lineage restricted and frequently 
cross-react with normal hematopoietic elements. Fur- 
thermore. most of these hematopoietic/lymphoreticula~ 
antibodies were developed and initially used as markers 
of malignant lymphomas (ie, mature lymph&t cells) and 
uniformly have not been leukemia restricted. Thus. par- 
affin section antibody studies have had significant linl- 
itations in the routine evaluation of acute leukemia. 
This is the first report of anti-CDS4 staining of acute 
leukemia in paraffin-embedded sections. In this study, 
we compared the reactivity of anti-CDS4 in paraffin sec- 
tions to that of routine flow cytometric immunophen- 
otyping. No significant discrepancies were identified 
between these two methodologies. The results suggest 
that anti-CD34 staining by immunoperoxidase methods 
may be diagnostically useful to pathologists evaluating 
bone marrow specimens for acute leukemia. CLIIIYII~ 
knowledge of the CD34 antigen does not explain why 
FIGURE 4. Anti-CD34 immunoperoxi- 
dose staining in a peripheral T-cell lym- 
phoma. Most of the endotheiial ceils 
show prominent staining with this anti- 
body. (Magnification x200.) 
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FIGURE 5. Anti-CD34 immunoperoxi- 
dase siaining of pericapsular, spindle- 
shaped cells. These cells have a den- 
dritic-like appearance. (Magnification 
,400.) 
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